Vol 1 (September 2016): Translational Gastroenterology and Hepatology

Editorial 
Eluxadoline: a promising therapy that raises many questions
Brooks D. Cash
Translational Gastroenterology and Hepatology  
2016;
1:
76  
Editorial 
Pathologic tumor response to neoadjuvant chemotherapy in gastroesophageal cancer: what does it mean?
Toshiyuki Kosuga, Daisuke Ichikawa, Eigo Otsuji
Translational Gastroenterology and Hepatology  
2016;
1:
75  
Case Report 
Interventional therapy for rectal neuroendocrine tumor with liver metastases: report of one case
Lingxiao Liu, Xu Han, Wenhui Lou
Translational Gastroenterology and Hepatology  
2016;
1:
74  
Case Report 
Metastatic multiple endocrine neoplasia type 1: report of one case
Cheng Huang, Xiaodong Zhu, Xu Han, Wenhui Lou
Translational Gastroenterology and Hepatology  
2016;
1:
73  
Editorial 
Splenic hilar dissection in the treatment of proximal advanced gastric cancer: what is an adequate strategy?
Takahiro Kinoshita
Translational Gastroenterology and Hepatology  
2016;
1:
72  
Commentary 
Impact of pathologic tumor response in the treatment of gastric cancer
Joyce Wong
Translational Gastroenterology and Hepatology  
2016;
1:
71  
Case Report 
Glucagonoma syndrome: report of one case
Xu Han, Dansong Wang, Tiantao Kuang, Yefei Rong, Wenhui Lou
Translational Gastroenterology and Hepatology  
2016;
1:
70  
Editorial 
Surgery for liver metastasis from gastric cancer
Guido Alberto Massimo Tiberio, Franco Roviello, Annibale Donini, Giovanni de Manzoni Giovanni de Manzoni, on behalf of the Italian Research Group for Gastric Cancer
Translational Gastroenterology and Hepatology  
2016;
1:
68  
Review Article 
Targeting angiogenesis in gastrointestinal tumors: current challenges
Amara G. Nandikolla, Lakshmi Rajdev
Translational Gastroenterology and Hepatology  
2016;
1:
67